首页|期刊导航|磁共振成像|MRI影像组学对原发性中枢神经系统淋巴瘤的鉴别诊断与预后评估的研究进展

MRI影像组学对原发性中枢神经系统淋巴瘤的鉴别诊断与预后评估的研究进展OA

Research progress of MRI radiomics in differential diagnosis and prognostic evaluation of primary central nervous system lymphoma

中文摘要英文摘要

原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)是一种侵袭性的结外淋巴瘤,在临床中呈罕见发病态势.因其肿瘤生物学行为的高度侵袭性,以及治疗方案受血脑屏障限制等因素,PCNSL患者的整体预后显著较差,是目前临床肿瘤学领域中极具诊疗挑战的淋巴瘤亚型之一.MRI现已广泛应用于中枢神经系统肿瘤的诊断及分级方面,但病灶内的分子学机制、肿瘤微环境及生物学进程仍需进一步探索.影像组学技术可以挖掘病灶更深层次的信息,能更客观、全面地评价肿瘤异质性,在各类肿瘤诊断、分级与预后评估展现出极大潜力.本文围绕MRI影像组学在PCNSL诊断及预后预测中的最新应用及研究进展展开综述,指出了当前研究的局限性及今后研究的方向,以期推动该领域的进一步发展.

Primary central nervous system lymphoma(PCNSL)is an aggressive extranodal lymphoma that remains clinically rare.Owing to its highly invasive tumor biology and the fact that therapeutic options are constrained by the blood-brain barrier,patients with PCNSL exhibit markedly poor overall prognosis,making PCNSL one of the most challenging lymphoma subtypes in contemporary clinical oncology.Although MRI is now widely used for the diagnosis and grading of central nervous system tumors,the underlying molecular mechanisms,tumor microenvironment,and biological processes within the lesions still require further exploration.Radiomics can mine deeper information from the tumor,enabling more objective and comprehensive assessment of tumor heterogeneity,and has shown great potential for diagnosis,grading,and prognosis prediction across various cancers.This review focuses on the latest applications and research advances of MRI-based radiomics in the diagnosis and prognostic prediction of PCNSL,highlights current limitations,and outlines future research directions,aiming to further advance the field.

钟琪;崔嘉成;徐东昊;许蕾

山东第二医科大学医学影像学院,潍坊 261053滨州医学院医学影像学院,烟台 264003胜利油田中心医院医学影像科,东营 257034胜利油田中心医院医学影像科,东营 257034

医药卫生

原发性中枢神经系统淋巴瘤磁共振成像人工智能影像组学诊断预后

primary central nervous system lymphomamagnetic resonance imagingartificial intelligenceradiomicsdiagnosisprognosis

《磁共振成像》 2026 (3)

168-173,6

National Key Clinical Specialty Construction Project(No.Guo Wei Ban Yi Han[2018]292). 国家临床重点专科建设项目(编号:国卫办医函[2018]292号)

10.12015/issn.1674-8034.2026.03.024

评论